Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
06 mai 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
03 mai 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Agios Reports Business Highlights and First Quarter 2024 Financial Results
02 mai 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
– Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now expected in Q2 2024 – – Announced Positive Results from the...
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
18 avr. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
09 avr. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
05 mars 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
22 févr. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
15 févr. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
Agios reports fourth quarter and full year 2023 financial results and recent business highlights
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024
02 févr. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced...
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
08 janv. 2024 07h00 HE
|
Agios Pharmaceuticals, Inc.
– Industry-leading PK Activator Franchise Has Demonstrated Clinical Efficacy in Four Hematological Diseases, Including New Positive Phase 3 Data in Non-Transfusion-Dependent Thalassemia – – Company...